Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2256098 and Trametinib in advanced pancreatic cancer
NCT02428270Phase 2Completed
- Sponsor
- University Health Network
- Start
- Apr 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GSK2256098 in pancreatic adenocarcinoma (PDAC), sponsored by University Health Network. Started Apr 2016; status: completed.
02
Drugs
GSK2256098
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02428270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02428270.